Teva Pharmaceutical Industries and Baxter Healthcare plan to appeal a combined $500 million in punitive damages in the first of nearly 250 civil cases stemming from a hepatitis C outbreak related to Teva's propofol drug two years ago. A Nevada jury awarded the damages to a plaintiff who says he contracted hepatitis C when one of Teva's drug vials was used by more than one patient.
May 11, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drugmaker Teva Pharmaceutical Industries Ltd. plans to appeal a $356 million Las Vegas district court verdict awarded to a plaintiff who says he contracted hepatitis C when one of Teva’s drug vials was used by more than one patient.
A jury in Las Vegas ordered Teva and Baxter Healthcare Corp. to pay a combined $500 million in punitive damages in the first of nearly 250 civil cases stemming from a hepatitis C outbreak related to its drug propofol two years ago.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
